Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single‐centre retrospective study in Beijing
Aim To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Methods Single‐centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010‐Apri...
Saved in:
Published in | NEPHROLOGY Vol. 25; no. 9; pp. 714 - 722 |
---|---|
Main Authors | , , , , , |
Format | Journal Article Publication |
Language | English |
Published |
Melbourne
John Wiley & Sons Australia, Ltd
01.09.2020
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1320-5358 1440-1797 1440-1797 |
DOI | 10.1111/nep.13714 |
Cover
Abstract | Aim
To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.
Methods
Single‐centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010‐April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression.
Results
Of 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1‐2); DN and HTN were common in advanced‐stages (stages 3‐4). In a longitudinal subcohort of 2923 patients with ≥6‐month follow‐up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro‐ and micro‐albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM).
Conclusion
This study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression.
SUMMARY AT A GLANCE
This study identified diabetic nephropathy was a strong predictor of faster disease progression, and confirmed albuminuria to be associated with highest risk for disease progression. |
---|---|
AbstractList | This study identified diabetic nephropathy was a strong predictor of faster disease progression, and confirmed albuminuria to be associated with highest risk for disease progression. To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.AIMTo assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.Single-centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010-April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression.METHODSSingle-centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010-April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression.Of 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1-2); DN and HTN were common in advanced-stages (stages 3-4). In a longitudinal subcohort of 2923 patients with ≥6-month follow-up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro- and micro-albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM).RESULTSOf 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1-2); DN and HTN were common in advanced-stages (stages 3-4). In a longitudinal subcohort of 2923 patients with ≥6-month follow-up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro- and micro-albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM).This study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression.CONCLUSIONThis study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression. To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Single-centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010-April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression. Of 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1-2); DN and HTN were common in advanced-stages (stages 3-4). In a longitudinal subcohort of 2923 patients with ≥6-month follow-up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro- and micro-albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM). This study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression. Aim To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Methods Single‐centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010‐April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression. Results Of 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1‐2); DN and HTN were common in advanced‐stages (stages 3‐4). In a longitudinal subcohort of 2923 patients with ≥6‐month follow‐up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro‐ and micro‐albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM). Conclusion This study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression. SUMMARY AT A GLANCE This study identified diabetic nephropathy was a strong predictor of faster disease progression, and confirmed albuminuria to be associated with highest risk for disease progression. AimTo assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.MethodsSingle‐centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010‐April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression.ResultsOf 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1‐2); DN and HTN were common in advanced‐stages (stages 3‐4). In a longitudinal subcohort of 2923 patients with ≥6‐month follow‐up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro‐ and micro‐albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM).ConclusionThis study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression. |
Author | Cabrera, Claudia Sui, Zhun Wang, Jiemin Wang, Mi Zuo, Li Wei, Jia |
AuthorAffiliation | 2 AstraZeneca Global R&D Information Shanghai China 4 Department of Medical Epidemiology and Biostatistics Karolinska Institute Stockholm Sweden 1 Department of Nephrology Peking University People's Hospital Beijing China 3 AstraZeneca R&D Gothenburg Sweden |
AuthorAffiliation_xml | – name: 2 AstraZeneca Global R&D Information Shanghai China – name: 4 Department of Medical Epidemiology and Biostatistics Karolinska Institute Stockholm Sweden – name: 3 AstraZeneca R&D Gothenburg Sweden – name: 1 Department of Nephrology Peking University People's Hospital Beijing China |
Author_xml | – sequence: 1 givenname: Zhun surname: Sui fullname: Sui, Zhun organization: Peking University People's Hospital – sequence: 2 givenname: Jiemin surname: Wang fullname: Wang, Jiemin organization: AstraZeneca Global R&D Information – sequence: 3 givenname: Claudia surname: Cabrera fullname: Cabrera, Claudia organization: Karolinska Institute – sequence: 4 givenname: Jia surname: Wei fullname: Wei, Jia organization: AstraZeneca Global R&D Information – sequence: 5 givenname: Mi surname: Wang fullname: Wang, Mi organization: Peking University People's Hospital – sequence: 6 givenname: Li orcidid: 0000-0002-7340-5995 surname: Zuo fullname: Zuo, Li email: zuolimd@hotmail.com organization: Peking University People's Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32180286$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:$$DView record from Swedish Publication Index |
BookMark | eNp9ks1uEzEQxy1URD_gwAsgS1zgsK2_svZyQApR-ZAq4ABna9c7Tpxs7GDvttobj4B4RJ4EpwkRrQSWLI9mfv_RzHhO0ZEPHhB6Ssk5zefCw-accknFA3RChSAFlZU8yjZnpJjwiTpGpyktCaGSlfQROuaMKsJUeYJ-TqF3oQvzEQeLzSIG7wxeudbDiFuXoE6Aa9_i6NIK29r0ISZsQzwENzHMI6TkgsfO49nCecjuNDRLMH16hac4OT_v4Nf3HwZ8HwFH6GNImxx215nsh3bcSt-AW2byMXpo6y7Bk_17hr6-vfwye19cfXr3YTa9KoxQVBQ1Kw2vLFSWlpaXypoWCGsqKURllRSmEdIq03BCy4YwKVTJmWRV1RBBWMX5GSp2edMNbIZGb6Jb13HUoXZ671plC3QphFAi8693fI6sob3tpe7uyO5GvFvoebjWUlQlIzQneLFPEMO3AVKv1y4Z6LraQxiSZlwqQhhRk4w-v4cuwxB9HodmgpN8-YRk6tnfFR1K-fO9GXi5A0yed4pgDwglers6Oq-Ovl2dzF7cY43r67wc22Zc9z_Fjetg_Hdq_fHy807xGzEQ2Ek |
CitedBy_id | crossref_primary_10_3389_fmed_2022_863275 crossref_primary_10_1155_2022_9613062 crossref_primary_10_1186_s12882_024_03711_x crossref_primary_10_2147_IJNRD_S248075 crossref_primary_10_1016_j_healthpol_2024_105244 crossref_primary_10_3389_fphar_2023_1108861 crossref_primary_10_1038_s41440_024_01698_4 crossref_primary_10_1111_jch_14776 crossref_primary_10_3389_fendo_2022_859266 |
Cites_doi | 10.1016/S0140-6736(12)60033-6 10.1681/ASN.2008080860 10.1159/000348638 10.1136/pmj.79.930.206 10.1056/NEJMoa1813599 10.1681/ASN.2017111163 10.1056/NEJMoa1901713 10.1159/000108755 10.1016/S0828-282X(07)70806-1 10.1038/sj.ijo.0803354 10.1093/ndt/gfn767 10.1371/journal.pone.0158765 10.2215/CJN.01730215 10.1053/j.ajkd.2007.11.009 10.7326/0003-4819-150-9-200905050-00006 10.1016/S0140-6736(13)60687-X 10.1093/ndt/gfn604 10.1016/j.cca.2007.09.020 10.1186/1471-2369-15-205 10.1056/NEJMc1602469 10.1111/j.1523-1755.2005.09416.x 10.1097/MD.0000000000003872 10.1038/sj.ki.5002481 10.1371/journal.pone.0047100 10.1053/j.ajkd.2014.08.023 10.1111/j.1440-1797.2011.01503.x 10.1007/s11255-012-0194-0 10.1111/j.1523-1755.2004.00837.x 10.1038/s41598-019-46857-7 10.1097/MD.0000000000003013 |
ContentType | Journal Article Publication |
Copyright | 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology. 2020 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology. 2020. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology. – notice: 2020 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology. – notice: 2020. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP K9. 7X8 5PM ADTPV BZJLE D8T STUKM |
DOI | 10.1111/nep.13714 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Other SWEPUB Freely available online SwePub Other full text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Sui et al |
EISSN | 1440-1797 |
EndPage | 722 |
ExternalDocumentID | oai_swepub_ki_se_644484 PMC7496201 32180286 10_1111_nep_13714 NEP13714 |
Genre | article Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: AstraZeneca – fundername: ; |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 24P 29M 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KMS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 XVB YFH ZZTAW ~IA ~WT AAYXX AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QP AAMMB AEFGJ AGXDD AIDQK AIDYY K9. 7X8 5PM ADTPV BZJLE D8T STUKM |
ID | FETCH-LOGICAL-c4814-a26c39fe9f16f368fcde02b97449f874cb47f8cb3016b027486327299b0402933 |
IEDL.DBID | DR2 |
ISSN | 1320-5358 1440-1797 |
IngestDate | Mon Sep 01 03:31:32 EDT 2025 Thu Aug 21 18:15:18 EDT 2025 Fri Jul 11 05:00:05 EDT 2025 Fri Jul 25 10:12:20 EDT 2025 Thu Apr 03 07:05:52 EDT 2025 Thu Apr 24 23:02:39 EDT 2025 Tue Jul 01 01:01:07 EDT 2025 Wed Jan 22 16:34:20 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | chronic kidney diseases hypertensive nephropathy disease progression diabetic nephropathies glomerulonephritis |
Language | English |
License | Attribution-NonCommercial 2020 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4814-a26c39fe9f16f368fcde02b97449f874cb47f8cb3016b027486327299b0402933 |
Notes | Funding information Zhun Sui and Jiemin Wang contributed equally to this article. AstraZeneca ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Funding information AstraZeneca |
ORCID | 0000-0002-7340-5995 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnep.13714 |
PMID | 32180286 |
PQID | 2430243350 |
PQPubID | 2045121 |
PageCount | 9 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_644484 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7496201 proquest_miscellaneous_2378002085 proquest_journals_2430243350 pubmed_primary_32180286 crossref_primary_10_1111_nep_13714 crossref_citationtrail_10_1111_nep_13714 wiley_primary_10_1111_nep_13714_NEP13714 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2020 |
PublicationDateYYYYMMDD | 2020-09-01 |
PublicationDate_xml | – month: 09 year: 2020 text: September 2020 |
PublicationDecade | 2020 |
PublicationPlace | Melbourne |
PublicationPlace_xml | – name: Melbourne – name: Australia – name: Richmond |
PublicationTitle | NEPHROLOGY |
PublicationTitleAlternate | Nephrology (Carlton) |
PublicationYear | 2020 |
Publisher | John Wiley & Sons Australia, Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons Australia, Ltd – name: Wiley Subscription Services, Inc |
References | 2002; 39 2004; 66 2018; 29 2009; 24 2019; 9 2009; 20 2003; 79 2016; 95 2009; 150 2013; 382 2007; 72 2013; 181 2007; 31 2008; 387 2008; 51 2011; 16 2019; 381 2005; 67 2016; 11 2012; 3 2015; 65 2008; 28 2014; 15 2019 2016; 375 2012; 379 2012; 7 2009; 19 2012; 44 2007; 23 e_1_2_8_28_1 e_1_2_8_29_1 National Kidney Foundation (e_1_2_8_15_1) 2002; 39 e_1_2_8_24_1 e_1_2_8_25_1 China Kidney Disease Network (CK‐NET) (e_1_2_8_27_1) 2019; 9 e_1_2_8_26_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 KDIGO (e_1_2_8_16_1) 2012; 3 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 Yao Q (e_1_2_8_23_1) 2009; 19 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
References_xml | – volume: 11 year: 2016 article-title: Global prevalence of chronic kidney disease—a systematic review and meta‐analysis publication-title: PLoS One – volume: 31 start-page: 177 year: 2007 end-page: 188 article-title: Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China publication-title: Int J Obes – volume: 16 start-page: 633 year: 2011 end-page: 641 article-title: Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI) publication-title: Nephrology (Carlton) – volume: 3 start-page: 136 year: 2012 end-page: 150 article-title: Clinical practice guideline for the evaluation and management of chronic kidney disease publication-title: Kidney Int Suppl – volume: 375 start-page: 905 year: 2016 end-page: 906 article-title: Trends in chronic kidney disease in China publication-title: N Engl J Med – volume: 181 start-page: 22 year: 2013 end-page: 30 article-title: Changing spectrum of biopsy‐proven primary glomerular diseases over the past 15 years: a single‐center study in China publication-title: Contrib Nephrol – volume: 51 start-page: 373 year: 2008 end-page: 384 article-title: Prevalence and factors associated with CKD: a population study from Beijing publication-title: Am J Kidney Dis – volume: 24 start-page: 2117 year: 2009 end-page: 2123 article-title: Community‐based study on CKD subjects and the associated risk factors publication-title: Nephrol Dial Transplant – volume: 28 start-page: 1 year: 2008 end-page: 7 article-title: Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China publication-title: Am J Nephrol – volume: 15 start-page: 205 year: 2014 article-title: Prevalence of chronic kidney disease and associated factors among the Chinese population in Taian, China publication-title: BMC Nephrol – volume: 79 start-page: 206 year: 2003 end-page: 213 article-title: Acute glomerulonephritis publication-title: Postgrad Med J – volume: 7 year: 2012 article-title: High prevalence and associated risk factors for impaired renal function and urinary abnormalities in a rural adult population from southern China publication-title: PLoS One – volume: 66 start-page: 920 year: 2004 end-page: 923 article-title: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies publication-title: Kidney Int – volume: 95 year: 2016 article-title: Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross‐sectional study publication-title: Medicine – volume: 29 start-page: 1411 year: 2018 end-page: 1425 article-title: Mechanism of hyperkalemia‐induced metabolic acidosis publication-title: J Am Soc Nephrol – volume: 39 start-page: S1 year: 2002 end-page: S266 article-title: K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification publication-title: Am J Kidney Dis – volume: 9 year: 2019 article-title: Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross‐sectional survey publication-title: Sci Rep – volume: 19 year: 2009 article-title: Dialysis status in China: a report from the Shanghai Dialysis Registry (2000‐2005) publication-title: Ethn Dis – volume: 381 start-page: 1011 year: 2019 end-page: 1022 article-title: Roxadustat treatment for anemia in patients undergoing long‐term dialysis publication-title: N Engl J Med – volume: 24 start-page: 1205 year: 2009 end-page: 1212 article-title: Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China publication-title: Nephrol Dial Transplant – volume: 150 start-page: 604 year: 2009 end-page: 612 article-title: A new equation to estimate glomerular filtration rate publication-title: Ann Intern Med – volume: 65 start-page: 147 year: 2015 end-page: 151 article-title: Peritoneal dialysis in China: meeting the challenge of chronic kidney failure publication-title: Am J Kidney Dis – volume: 72 start-page: S4 year: 2007 end-page: S9 article-title: Anemia as a risk factor for chronic kidney disease publication-title: Kidney Int Suppl – volume: 382 start-page: 260 year: 2013 end-page: 272 article-title: Chronic kidney disease: global dimension and perspectives publication-title: Lancet – volume: 11 start-page: 90 year: 2016 end-page: 100 article-title: Association between serum potassium and outcomes in patients with reduced kidney function publication-title: Clin J Am Soc Nephrol – volume: 95 year: 2016 article-title: Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta‐analysis publication-title: Medicine – volume: 9 start-page: e1 year: 2019 end-page: e81 article-title: 2015 Annual Data Report publication-title: Kidney Int Suppl – volume: 67 start-page: S63 year: 2005 end-page: S67 article-title: Prevention of the progression of chronic kidney disease: practice in China publication-title: Kidney Int Suppl – volume: 387 start-page: 128 year: 2008 end-page: 132 article-title: Investigation of the prevalence of CKD in 13,383 Chinese hospitalised adult patients publication-title: Clin Chim Acta – volume: 44 start-page: 1269 year: 2012 end-page: 1276 article-title: Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990‐1991 and 2009‐2010 publication-title: Int Urol Nephrol – volume: 381 start-page: 1001 year: 2019 end-page: 1010 article-title: Roxadustat for anemia in patients with kidney disease not receiving dialysis publication-title: N Engl J Med – volume: 23 start-page: 585 year: 2007 end-page: 590 article-title: Improving outcomes in diabetes and chronic kidney disease: the basis for Canadian guidelines publication-title: Can J Cardiol – volume: 20 start-page: 1199 year: 2009 end-page: 1209 article-title: Prediction, progression, and outcomes of chronic kidney disease in older adults publication-title: J Am Soc Nephrol – year: 2019 – volume: 379 start-page: 815 year: 2012 end-page: 822 article-title: Prevalence of chronic kidney disease in China: a cross‐sectional survey publication-title: Lancet – ident: e_1_2_8_3_1 doi: 10.1016/S0140-6736(12)60033-6 – ident: e_1_2_8_12_1 doi: 10.1681/ASN.2008080860 – ident: e_1_2_8_20_1 doi: 10.1159/000348638 – ident: e_1_2_8_9_1 doi: 10.1136/pmj.79.930.206 – ident: e_1_2_8_26_1 doi: 10.1056/NEJMoa1813599 – ident: e_1_2_8_36_1 doi: 10.1681/ASN.2017111163 – ident: e_1_2_8_25_1 doi: 10.1056/NEJMoa1901713 – volume: 3 start-page: 136 year: 2012 ident: e_1_2_8_16_1 article-title: Clinical practice guideline for the evaluation and management of chronic kidney disease publication-title: Kidney Int Suppl – ident: e_1_2_8_21_1 doi: 10.1159/000108755 – volume: 39 start-page: S1 year: 2002 ident: e_1_2_8_15_1 article-title: K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification publication-title: Am J Kidney Dis – ident: e_1_2_8_29_1 doi: 10.1016/S0828-282X(07)70806-1 – ident: e_1_2_8_24_1 doi: 10.1038/sj.ijo.0803354 – volume: 9 start-page: e1 year: 2019 ident: e_1_2_8_27_1 article-title: 2015 Annual Data Report publication-title: Kidney Int Suppl – ident: e_1_2_8_5_1 doi: 10.1093/ndt/gfn767 – ident: e_1_2_8_31_1 doi: 10.1371/journal.pone.0158765 – ident: e_1_2_8_13_1 doi: 10.2215/CJN.01730215 – ident: e_1_2_8_4_1 doi: 10.1053/j.ajkd.2007.11.009 – ident: e_1_2_8_14_1 doi: 10.7326/0003-4819-150-9-200905050-00006 – ident: e_1_2_8_35_1 – ident: e_1_2_8_2_1 doi: 10.1016/S0140-6736(13)60687-X – volume: 19 year: 2009 ident: e_1_2_8_23_1 article-title: Dialysis status in China: a report from the Shanghai Dialysis Registry (2000‐2005) publication-title: Ethn Dis – ident: e_1_2_8_7_1 doi: 10.1093/ndt/gfn604 – ident: e_1_2_8_32_1 doi: 10.1016/j.cca.2007.09.020 – ident: e_1_2_8_6_1 doi: 10.1186/1471-2369-15-205 – ident: e_1_2_8_17_1 doi: 10.1056/NEJMc1602469 – ident: e_1_2_8_22_1 doi: 10.1111/j.1523-1755.2005.09416.x – ident: e_1_2_8_18_1 doi: 10.1097/MD.0000000000003872 – ident: e_1_2_8_34_1 doi: 10.1038/sj.ki.5002481 – ident: e_1_2_8_8_1 doi: 10.1371/journal.pone.0047100 – ident: e_1_2_8_10_1 doi: 10.1053/j.ajkd.2014.08.023 – ident: e_1_2_8_30_1 doi: 10.1111/j.1440-1797.2011.01503.x – ident: e_1_2_8_11_1 doi: 10.1007/s11255-012-0194-0 – ident: e_1_2_8_19_1 doi: 10.1111/j.1523-1755.2004.00837.x – ident: e_1_2_8_28_1 doi: 10.1038/s41598-019-46857-7 – ident: e_1_2_8_33_1 doi: 10.1097/MD.0000000000003013 |
SSID | ssj0017261 |
Score | 2.314155 |
Snippet | Aim
To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.
Methods
Single‐centre retrospective... This study identified diabetic nephropathy was a strong predictor of faster disease progression, and confirmed albuminuria to be associated with highest risk... To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Single-centre retrospective study... AimTo assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.MethodsSingle‐centre retrospective study... To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.AIMTo assess the aetiological factors of... |
SourceID | swepub pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 714 |
SubjectTerms | Acidosis Aged China - epidemiology chronic kidney diseases Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology diabetic nephropathies Diabetic Nephropathies - complications Diabetic Nephropathies - diagnosis Diabetic Nephropathies - epidemiology Disease Progression Electronic medical records Etiology Female Glomerulonephritis Humans Hypertension, Renal - complications Hypertension, Renal - epidemiology hypertensive nephropathy Kidney diseases Male Metabolic acidosis Middle Aged Multivariate analysis Nephritis - complications Nephritis - epidemiology Nephropathy Original Patients Renal Insufficiency, Chronic - diagnosis Renal Insufficiency, Chronic - epidemiology Renal Insufficiency, Chronic - etiology Retrospective Studies Risk Assessment - methods Risk Assessment - statistics & numerical data Risk Factors |
Title | Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single‐centre retrospective study in Beijing |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnep.13714 https://www.ncbi.nlm.nih.gov/pubmed/32180286 https://www.proquest.com/docview/2430243350 https://www.proquest.com/docview/2378002085 https://pubmed.ncbi.nlm.nih.gov/PMC7496201 http://kipublications.ki.se/Default.aspx?queryparsed=id |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SFEovfT_cpotaSunFy9rSynJy2m2yhEJDKA3kUDCWLJHtBm_Y9R7aU39C6U_ML8noYVM3LZTejDXCSJ4ZfSONvgF4rXMMq4zRMeU8j5k0aSy54LHEtchwYyStXILsET88Ye9Px6dbsNfehfH8EN2Gm7UM56-tgZdy_YuR1_pimFi-OfS_CeWWN3__Y0cdhesyT9obwmM6FoFVyGbxdD37a9E1gHk9TzKwifaBrFuJZnfhczsGn4CyGG4aOVTffqN3_M9B3oM7AaGSiVep-7Cl6wdw60M4g38IPye68XdcyNIQ5cl1yWJe1forCec9pKwrYrPWSajnQxAbd40uJ8zzgZB5TWwJb42v1xtpN4XWu2RC7A7Gub78_sNNiiYr3ayW7a1Q4jhxbdepnn9ByUdwMjv49O4wDpUdYsVEwuIy5YrmRucm4YZyYVSlR6nE2IblRmRMSZYZoSR6Hy5t4Cw4TTEMyCX6HAQo9DFs18taPwViMGQ0CqNO9FUITjKZVblkOsvLkVHYM4K37T8uVKA9t9U3zos2_ME5LtwcR_CqE73wXB9_EtppFaUI5r4uUkYtsyMdjyJ42TWjodrTl7LWyw3K0Ez4kqgRPPF61X2FppaIT_AIsp7GdQKWBLzfUs_PHBl4xnKOIC6CN143e13CqwU-6QKRLxN2PpzC_X2ExdHBsXt49u-iz-F2ajciXPLdDmw3q41-gWitkQO4kbLjAdycTPens4Ez0iuiEUHJ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VIgEX_qGBAgYhxCWr3djr2IjLAq0WaFcItVIvVbR2bLHdKlvtZg9w4hEQj8iTMP5JRChIiFsUjxXZmbG_GY-_AXhqJLpV1pqUci5TpmyWKi54qnAvstxaRUufIDvh40P27mh4tAEvm7swgR-iDbg5y_DrtTNwF5D-xcorc9YbOMK5C3CRIdBwrtebjy15FO7MfNDcER7SoYi8Qi6Pp-3a3Y3OQczzmZKRT7QLZf1etHsNjptRhBSUeW9dq57-8hvB4_8O8zpcjSCVjIJW3YANU92ES_vxGP4WfB-ZOlxzIQtLdODXJfNZWZnPJB75kGlVEpe4TmJJH4LwuG30aWGBEoTMKuKqeBt8vVorFxdavSAj4oIYp-bH129-VgxZmnq5aC6GEk-L67q-MrMTlLwNh7s7B6_HaSzukGomBiydZlxTaY20A24pF1aXpp8pdG-YtCJnWrHcCq1wAeLK-c6C0ww9Aalw2UGMQu_AZrWozBYQi16j1eh44nKF-CRXeSkVM7mc9q3Gngk8b35yoSPzuSvAcVo0HhDOceHnOIEnrehZoPv4k9B2oylFtPhVkTHqyB3psJ_A47YZbdUdwEwrs1ijDM1FqIqawN2gWO1XaOa4-ARPIO-oXCvgeMC7LdXsk-cDz5nkiOMSeBaUs9MlvprjkykQ_DLh5sNr3N9HWEx2PviHe_8u-ggujw_294q9t5P39-FK5uISPhdvGzbr5do8QPBWq4feRn8C5tRDnw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB6VIlVcKM-ypYBBCHHZKFk7XhtOARqVV1QhKvWAtIq9tgipNlGyOcCJn4D4ifwSxo9dsRQkxM2yx1rZO2N_Y4-_AXhoJLpV1pqUci5TpmyWKi54qnAvstxaRUsfIDvhRyfs1enwdAueNm9hAj9Ee-DmLMOv187Al6X9xcgrs-wNHN_cBbjIOCIJh4jetdxRuDHzQfNEeEiHItIKuTCetmt3MzqHMM8HSkY60S6S9VvReBc-NIMIESjz3qZWPf3lN37H_xzlFbgcISoZBZ26ClumugY7b-Ml_HX4PjJ1eORCFpbowK5L5rOyMp9JvPAh06okLmydxIQ-BMFx2-iDwgIhCJlVxOXwNli93ih3KrR-QkbEHWGcmR9fv_lJMWRl6tWieRZKPCmu6_rMzD6h5A04GR--f36UxtQOqWZiwNJpxjWV1kg74JZyYXVp-plC54ZJK3KmFcut0AqXH66c5yw4zdAPkAoXHUQo9CZsV4vK3AJi0We0Gt1OXKwQneQqL6ViJpfTvtXYM4HHzT8udOQ9d-k3zorG_8E5LvwcJ_CgFV0Gso8_CR00ilJEe18XGaOO2pEO-wncb5vRUt31y7Qyiw3K0FyEnKgJ7AW9ar9CM8fEJ3gCeUfjWgHHAt5tqWYfPRt4ziRHFJfAo6CbnS6xao4lUyD0ZcLNh1e4v4-wmBwe-8L-v4veg53jF-PizcvJ69twKXOHEj4Q7wC269XG3EHkVqu73kJ_AvdhQk4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aetiology+of+chronic+kidney+disease+and+risk+factors+for+disease+progression+in+Chinese+subjects%3A+A+single%E2%80%90centre+retrospective+study+in+Beijing&rft.jtitle=Nephrology+%28Carlton%2C+Vic.%29&rft.au=Sui%2C+Zhun&rft.au=Wang%2C+Jiemin&rft.au=Cabrera%2C+Claudia&rft.au=Wei%2C+Jia&rft.date=2020-09-01&rft.issn=1320-5358&rft.eissn=1440-1797&rft.volume=25&rft.issue=9&rft.spage=714&rft.epage=722&rft_id=info:doi/10.1111%2Fnep.13714&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_nep_13714 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1320-5358&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1320-5358&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1320-5358&client=summon |